Patient clarity
Baseline first
Screening helps identify what is measurable today.
MMS uses this as part of a structured conversation, not as a standalone instruction or treatment recommendation.
Longevity Medicine
Ageing well deserves medical judgement, not hype.
MMS approaches longevity through baseline understanding, evidence-informed discussion and professional review.
Your MMS guide
Ling
Longevity is not one treatment. I’ll help you understand the measurements, questions and evidence before your MMS doctor personalises the next step.
Physician-led care
Professional review before recommendations.
Personalised to you
No one-size-fits-all health pathway.
Trusted & private
Discretion, clarity and continuity.
Science + humanity
Evidence-aware, compassion-led.
Healthy ageing
Longevity is most credible when it is personal and measured.
The right questions are usually about resilience, energy, metabolic health, recovery and long-term independence.
Patient clarity
Context matters
Lifestyle, sleep, stress and family history shape the conversation.
MMS uses this as part of a structured conversation, not as a standalone instruction or treatment recommendation.
Patient clarity
Follow over time
Longer-view planning is more useful than one dramatic intervention.
MMS uses this as part of a structured conversation, not as a standalone instruction or treatment recommendation.
Evidence hierarchy
Not every health innovation deserves the same confidence.
MMS should make the level of certainty visible before discussing suitability. That protects trust and makes advanced care easier to understand.
01
Established
Standard preventive and clinical care
Approaches supported by mature guidelines, routine clinical use and clearer benefit–risk expectations.
02
Evidence-supported
Useful for selected people
Approaches with meaningful evidence that still depend strongly on indication, patient selection, clinician judgement and context.
03
Emerging
Promising, but not settled
Newer diagnostics or interventions where evidence, long-term outcomes, regulation or appropriate use may still be evolving.
04
Investigational
Research, not routine care
Interventions that should be discussed with explicit uncertainty, regulatory awareness and no implied outcome promise.
This is an MMS communication framework, not a substitute for treatment-specific evidence review. The classification of any individual test or intervention should be based on current evidence, regulation and professional assessment.
Professional review
Advanced longevity discussions require careful boundaries.
Suitability, uncertainty and individual variation should remain visible before any programme is considered.
01
Understand
Clarify the question before choosing the pathway.
02
Assess
Use screening and context to build a safer picture.
03
Review
Let qualified professionals decide what is appropriate.
04
Plan
Create a practical next step with realistic boundaries.
05
Follow
Keep continuity visible after the visit.
Care team beside you
The best next step is explained by people, not pushed by a page.
MMS uses education, screening and doctor review to turn a health question into a calmer, more credible plan.
Education first
Doctor-led
Continuity
Begin
Build longevity on clarity, not promises.
Start with clarity, then decide with professional guidance.
